Global Pharmaceutical Analytical Service Market Growth (Status and Outlook) 2025-2031

The global Pharmaceutical Analytical Service market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Pharmaceutical Analytical Service refers to the scientific testing and analysis of pharmaceutical products to ensure their quality, safety, and efficacy. It involves various analytical techniques and methods to evaluate the chemical composition, physical properties, and performance of pharmaceutical drugs and related materials.

Pharmaceutical analytical services are typically provided by specialized laboratories or companies that have expertise in pharmaceutical analysis. These services are crucial in the development, manufacturing, and quality control of pharmaceutical products. They help pharmaceutical companies to comply with regulatory requirements, such as those set by the Food and Drug Administration (FDA) in the United States.

Some common pharmaceutical analytical services include:

1. Method development and validation: Developing and validating analytical methods to accurately measure the concentration and purity of active pharmaceutical ingredients (APIs) and other components in a drug formulation.

2. Stability testing: Assessing the stability of pharmaceutical products under various storage conditions to determine their shelf life and ensure that they remain safe and effective throughout their intended use.

3. Impurity analysis: Identifying and quantifying impurities or degradation products in pharmaceutical products, which may arise during manufacturing, storage, or use.

4. Dissolution testing: Evaluating the rate at which a drug substance dissolves in a specified medium, which is important for determining its bioavailability and ensuring consistent drug release.

5. Particle size analysis: Measuring the size distribution of particles in pharmaceutical formulations, as it can affect the drug"s performance, stability, and bioavailability.

6. Microbiological testing: Assessing the microbial contamination of pharmaceutical products to ensure they meet the required standards for sterility and safety.

7. Elemental analysis: Determining the elemental composition of pharmaceutical materials, such as metals or trace elements, which can impact product quality and safety.

8. Bioanalytical testing: Analyzing biological samples, such as blood or urine, to measure drug concentrations or assess the pharmacokinetics and pharmacodynamics of a drug.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Pharmaceutical Analytical Service Industry Forecast” looks at past sales and reviews total world Pharmaceutical Analytical Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Analytical Service sales for 2025 through 2031. With Pharmaceutical Analytical Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Analytical Service industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Analytical Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharmaceutical Analytical Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Analytical Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Analytical Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Analytical Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Analytical Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
Chromatographic Techniques
Spectroscopic Techniques
Other

Segmentation by Application:
Enterprise
Research Institute

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alfa Chemistry
Intertek
Lonza
Solvias
Aurigene Pharmaceutical Services
Vetter
NUVISAN
BCM Analytical Services
Callidus Research Laboratories
BRS Analytical Services
Cambridge Pharma
API
Lifecore Biomedical
Glatt
Vectura
Symbiosis Pharmaceutical Services
Conscio Pharmaceuticals

Please note: The report will take approximately 2 business days to prepare and deliver.